INS and cancer: The pathway linking insulin production to cancer outcomes independent of glycemic control and insulin resistance is suggested to involve tumorigenesis driven by increased insulin, IGF 1 and IGF 2, collectively signaling through both insulin and IGF-1 receptors [31].